| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910830271103321 |
|
|
Titolo |
Biomedical applications and toxicology of carbon nanomaterials / / edited by Chunying Chen and Haifang Wang |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Company KGaA, , [2016] |
|
©2016 |
|
|
|
|
|
|
|
|
|
ISBN |
|
3-527-69287-8 |
3-527-69285-1 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (671 p.) |
|
|
|
|
|
|
Soggetti |
|
Nanostructured materials |
Biomedical materials |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index |
|
|
|
|
|
|
Nota di contenuto |
|
Related Titles; Title Page; Copyright; Table of Contents; List of Contributors; Preface; Chapter 1: Synthesis, Functionalization, and Characterization; 1.1 Introduction; 1.2 Fullerenes and Metallofullerenes; 1.3 Carbon Nanotubes; 1.4 Graphene; 1.5 Summary and Outlook; References; Chapter 2: Identification and Detection of Carbon Nanomaterials in Biological Systems; 2.1 Introduction; 2.2 Available Techniques for Qualitative and Quantitative Determination; 2.3 Summary and Outlook; Acknowledgments; References; Chapter 3: Biodistribution and Pharmacokinetics of Carbon Nanomaterials In Vivo |
3.1 Introduction3.2 Amorphous Carbon Nanoparticles; 3.3 sp2 Carbon Nanomaterials; 3.4 Nanodiamonds; 3.5 Summary and Outlook; Acknowledgments; References; Chapter 4: Interaction of Carbon Nanomaterials and Components in Biological Systems; 4.1 Introduction; 4.2 Factors Affecting Interaction; 4.3 Interaction of Carbon Nanomaterials with Various Components in Biological Systems; 4.4 Conclusion and Perspectives; References; Chapter 5: Biomedical Applications of Carbon Nanomaterials; 5.1 Introduction; 5.2 Biomedical Applications of Fullerenes; 5.3 Biomedical Applications of Carbon Nanotubes |
5.4 Biomedical Applications of Graphene5.5 Conclusion and |
|
|
|
|
|
|
|
|
|
|
Perspectives; Acknowledgments; References; Chapter 6: Pulmonary Effects of Carbon Nanomaterials; 6.1 Introduction; 6.2 Physicochemical Properties of Carbon Nanomaterials; 6.3 Fate of Pulmonary Exposed Carbon Nanoparticles (Deposition, Distribution, Translocation, and Clearance); 6.4 Carbon Nanomaterial-Induced Lung Responses; 6.5 Summary; Disclaimer; References; Chapter 7: Cardiovascular and Hemostatic Effects of Carbon Nanomaterials; 7.1 Background; 7.2 Carbon Nanotubes; 7.3 Fullerenes; 7.4 Graphene-Related Nanomaterials |
7.5 Conclusions and OutlookAcknowledgments; References; Chapter 8: Modulation of the Immune System by Fullerene and Graphene Derivatives; 8.1 Introduction; 8.2 The Immunological Effects of Fullerene and Its Derivatives; 8.3 Immunological Effects of Graphene and Its Derivatives; 8.4 Perspectives and Outlook; References; Chapter 9: Neuro-, Hepato-, and Nephrotoxicity of Carbon-based Nanomaterials; 9.1 Carbon-based Nanomaterials: Introduction; 9.2 Neurotoxicity of Carbon-based Nanomaterials; 9.3 Hepato and Nephrotoxicity of Carbon-based Nanomaterials |
9.4 Points of Consideration for Toxicity Evaluation of Carbon-based Nanomaterials9.5 Summary; Acknowledgments; References; Chapter 10: Genotoxicity and Carcinogenic Potential of Carbon Nanomaterials; 10.1 Introduction; 10.2 Carbon Nanomaterials: Genotoxicity and Carcinogenic Potential; 10.3 Future Challenges in Carbon Nanomaterial Carcinogenesis Risk Assessment; 10.4 Assessment of ECNM-Induced Genotoxicity and Carcinogenesis; 10.5 Concluding Remarks; Acknowledgments; Disclaimer; References; Chapter 11: Effect on Reproductive System of Carbon Nanomaterials; 11.1 Introduction |
11.2 Effects of Carbon Nanomaterials on the Reproductive System |
|
|
|
|
|
| |